Tilray | TRLY - Capital Ordinaire

Prix De L'Action
8.43
Variation Quotidienne
-0.53 -5.92%
Mensuellement
0.96%
Annuel
1,139.71%
Q2 Prévisions
9.04




Capital Ordinaire Changement Date
Acasti Pharma USD 1000 261.04M 2024-12
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Canopy Growth CAD 368.28M 35.9M 2025-12
Cronos Group USD 382.89M 286.14M 2025-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 169.6M 700K 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Moderna USD 391M 2M 2025-09
Organigram Holdings CAD 135.13M 671.75K 2025-12
Organon & Co USD 259.98M 18K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zealand Pharma A/S 70.61M 319.68K 2025-12